180 related articles for article (PubMed ID: 36965349)
1. Cannabinoids and the placenta: Receptors, signaling and outcomes.
Rokeby ACE; Natale BV; Natale DRC
Placenta; 2023 Apr; 135():51-61. PubMed ID: 36965349
[TBL] [Abstract][Full Text] [Related]
2. Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction.
Chang X; Bian Y; He Q; Yao J; Zhu J; Wu J; Wang K; Duan T
Cell Physiol Biochem; 2017; 42(2):537-550. PubMed ID: 28578322
[TBL] [Abstract][Full Text] [Related]
3. Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis.
Dochez-Arnault J; Desdoits-Lethimonier C; Matias I; Evrard B; Lagarrigue M; Toupin M; Lardenois A; Chalmel F; Mazaud-Guittot S; Dejucq-Rainsford N; Gely-Pernot A
BMC Med; 2023 Jul; 21(1):219. PubMed ID: 37430350
[TBL] [Abstract][Full Text] [Related]
4. Effects of a combination of cannabidiol and delta-9-tetrahydrocannabinol on key biological functions of HTR-8/SVneo extravillous trophoblast cells.
Alves P; Amaral C; Teixeira N; Correia-da-Silva G
Toxicology; 2023 Aug; 495():153614. PubMed ID: 37567336
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cannabinoid plasma concentration, maternal health, and cytokine levels in a rat model of prenatal Cannabis smoke exposure.
Black T; Baccetto SL; Barnard IL; Finch E; McElroy DL; Austin-Scott FVL; Greba Q; Michel D; Zagzoog A; Howland JG; Laprairie RB
Sci Rep; 2023 Nov; 13(1):21070. PubMed ID: 38030657
[TBL] [Abstract][Full Text] [Related]
6. The Cannabinoid Delta-9-tetrahydrocannabinol Disrupts Estrogen Signaling in Human Placenta.
Maia J; Almada M; Midão L; Fonseca BM; Braga J; Gonçalves D; Teixeira N; Correia-da-Silva G
Toxicol Sci; 2020 Oct; 177(2):420-430. PubMed ID: 32647869
[TBL] [Abstract][Full Text] [Related]
7. Δ9-tetrahydrocannabinol exposure during rat pregnancy leads to symmetrical fetal growth restriction and labyrinth-specific vascular defects in the placenta.
Natale BV; Gustin KN; Lee K; Holloway AC; Laviolette SR; Natale DRC; Hardy DB
Sci Rep; 2020 Jan; 10(1):544. PubMed ID: 31953475
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Consequences of Gestational Cannabinoid Exposure.
Lee K; Hardy DB
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502436
[TBL] [Abstract][Full Text] [Related]
9. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG
Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.
Moore CF; Weerts EM
Psychopharmacology (Berl); 2022 May; 239(5):1397-1408. PubMed ID: 34652500
[TBL] [Abstract][Full Text] [Related]
11. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
[TBL] [Abstract][Full Text] [Related]
12. Synthetic cannabinoids JWH-018, JWH-122, UR-144 and the phytocannabinoid THC activate apoptosis in placental cells.
Almada M; Alves P; Fonseca BM; Carvalho F; Queirós CR; Gaspar H; Amaral C; Teixeira NA; Correia-da-Silva G
Toxicol Lett; 2020 Feb; 319():129-137. PubMed ID: 31730886
[TBL] [Abstract][Full Text] [Related]
13. CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure.
Lambros AM; Sagar KA; Dahlgren MK; Kosereisoglu D; El-Abboud C; Smith RT; Gruber SA
Sci Rep; 2023 Apr; 13(1):5869. PubMed ID: 37041309
[TBL] [Abstract][Full Text] [Related]
14. Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol.
Černe K
Arh Hig Rada Toksikol; 2020 Mar; 71(1):1-11. PubMed ID: 32597140
[TBL] [Abstract][Full Text] [Related]
15. Prenatal cannabinoid and gene expression for neural adhesion molecule L1 in the fetal rat brain.
Gómez M; Hernández M; Johansson B; de Miguel R; Ramos JA; Fernández-Ruiz J
Brain Res Dev Brain Res; 2003 Dec; 147(1-2):201-7. PubMed ID: 15068010
[TBL] [Abstract][Full Text] [Related]
16. Examining the role of cannabinoids on osteoporosis: a review.
Clouse G; Penman S; Hadjiargyrou M; Komatsu DE; Thanos PK
Arch Osteoporos; 2022 Nov; 17(1):146. PubMed ID: 36401719
[TBL] [Abstract][Full Text] [Related]
17. Chronic prenatal delta-9-tetrahydrocannabinol exposure adversely impacts placental function and development in a rhesus macaque model.
Roberts VHJ; Schabel MC; Boniface ER; D'Mello RJ; Morgan TK; Terrobias JJD; Graham JA; Borgelt LM; Grant KA; Sullivan EL; Lo JO
Sci Rep; 2022 Nov; 12(1):20260. PubMed ID: 36424495
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol and Δ8-Tetrahydrocannabinol: Cannabinoids of Rising Interest and Concern.
White RM
Forensic Sci Rev; 2023 Jan; 35(1):27-45. PubMed ID: 36575371
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic Changes and the Roles of Cannabinoid Receptors and PPARγ in Developmental Toxicities Following Exposure to Δ9-Tetrahydrocannabinol and Cannabidiol.
Pandelides Z; Aluru N; Thornton C; Watts HE; Willett KL
Toxicol Sci; 2021 Jul; 182(1):44-59. PubMed ID: 33892503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
